Bafna Pharmaceuticals Ltd. logo

Bafna Pharmaceuticals Ltd. (BAFNAPH)

Market Closed
16 Oct, 10:00 PM
MSE MSE
₹
468. 65
+9.15
+1.9913%
₹
2.52B Market Cap
- P/E Ratio
- Div Yield
72,951 Volume
- Eps
₹ 459.5
Previous Close
Add Transaction
Day Range
460 468.65
Year Range
95 468.65
Want to track BAFNAPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bafna Pharmaceuticals Ltd. (BAFNAPH) Statistics

Valuation metrics

Market Cap 2.52B
Enterprise value 9.89B
Trailing P/E (ttm) 127.05
Forward P/E -
PEG ratio -22.17
Price/Sales (ttm) 6.84
Price/Book (mrq) 10.88
Enterprise Value/Revenue 6.84
Enterprise Value/EBITDA 59.52

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.67K
Average volume (90 days) 5.23K

Price summary

52-Week low 95
52-Week high 468.65
Beta -
50-Day moving average 328.86
200-Day moving average 220.76

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 26 Aug 2019

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.05%
Operating margin 0.08%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.08%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 57.72
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.11
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.81
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 1.57%
Book value per share (mrq) 38.41

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -